Center for Clinical Research and Health Promotion, University of Puerto Rico Medical Sciences Campus, School of Dental Medicine, San Juan, PR, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
J Hum Hypertens. 2017 Dec;32(1):26-33. doi: 10.1038/s41371-017-0009-y. Epub 2017 Nov 7.
Short-term blood pressure variability is associated with pre-diabetes/diabetes cross-sectionally, but there are no longitudinal studies evaluating this association. The objective of this study is to evaluate the association between within-visit systolic and diastolic blood pressure variability and development of pre-diabetes/diabetes longitudinally. The study was conducted among eligible participants from the San Juan Overweight Adults Longitudinal Study (SOALS), who completed the 3-year follow-up exam. Participants were Hispanics, 40-65 years of age, and free of diabetes at baseline. Within-visit systolic and diastolic blood pressure variability was defined as the maximum difference between three measures, taken a few minutes apart, of systolic and diastolic blood pressure, respectively. Diabetes progression was defined as development of pre-diabetes/diabetes over the follow-up period. We computed multivariate incidence rate ratios adjusting for baseline age, gender, smoking, physical activity, waist circumference, and hypertension status. Participants with systolic blood pressure variability ≥10 mmHg compared to those with <10 mmHg, showed higher progression to pre-diabetes/diabetes (RR = 1.77, 95% CI: 1.30-2.42). The association persisted among never smokers. Diastolic blood pressure variability ≥10 mmHg (compared to <10 mmHg) did not show an association with diabetes status progression (RR = 1.20, 95% CI: 0.71-2.01). Additional adjustment of baseline glycemia, C-reactive protein, and lipids (reported dyslipidemia or baseline HDL or triglycerides) did not change the estimates. Systolic blood pressure variability may be a novel independent risk factor and an early predictor for diabetes, which can be easily incorporated into a single routine outpatient visit at none to minimal additional cost.
短期血压变异性与糖尿病前期/糖尿病呈横断面相关,但尚无纵向研究评估这种相关性。本研究旨在评估就诊内收缩压和舒张压变异性与糖尿病前期/糖尿病的纵向发展之间的相关性。该研究在圣胡安超重成年人纵向研究(SOALS)中进行,符合条件的参与者完成了 3 年的随访检查。参与者为西班牙裔,年龄在 40-65 岁之间,基线时无糖尿病。就诊内收缩压和舒张压变异性定义为三次测量之间的最大差异,分别为收缩压和舒张压的几分钟测量值。糖尿病进展定义为随访期间出现糖尿病前期/糖尿病。我们计算了调整基线年龄、性别、吸烟、体力活动、腰围和高血压状态后的多变量发病率比。与收缩压变异性<10mmHg 的参与者相比,收缩压变异性≥10mmHg 的参与者发生糖尿病前期/糖尿病的进展风险更高(RR=1.77,95%CI:1.30-2.42)。从不吸烟者中也存在这种关联。舒张压变异性≥10mmHg(与<10mmHg 相比)与糖尿病状态进展无相关性(RR=1.20,95%CI:0.71-2.01)。进一步调整基线血糖、C 反应蛋白和脂质(报告血脂异常或基线 HDL 或甘油三酯)并未改变估计值。收缩压变异性可能是糖尿病的一个新的独立危险因素和早期预测指标,可在无额外费用或仅需少量额外费用的情况下轻松纳入单次常规门诊就诊。